Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $80,377 | 19 | 94.7% |
| Travel and Lodging | $3,860 | 11 | 4.5% |
| Food and Beverage | $618.41 | 8 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB SA | $41,845 | 19 | $0 (2017) |
| Pacira Therapeutics, Inc. | $15,817 | 3 | $0 (2021) |
| JAZZ PHARMACEUTICALS INC. | $8,965 | 2 | $0 (2019) |
| Novartis Pharma AG | $8,569 | 6 | $0 (2017) |
| Halozyme Inc | $5,735 | 4 | $0 (2019) |
| PTC Therapeutics, Inc. | $3,924 | 4 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $3,924 | 4 | PTC Therapeutics, Inc. ($3,924) |
| 2021 | $15,817 | 3 | Pacira Therapeutics, Inc. ($15,817) |
| 2019 | $10,160 | 3 | JAZZ PHARMACEUTICALS INC. ($8,965) |
| 2018 | $4,540 | 3 | Halozyme Inc ($4,540) |
| 2017 | $50,414 | 25 | UCB SA ($41,845) |
All Payment Transactions
38 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/17/2022 | PTC Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $997.50 | General |
| 05/16/2022 | PTC Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $665.00 | General |
| 05/15/2022 | PTC Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,330.00 | General |
| 05/09/2022 | PTC Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $931.00 | General |
| 06/30/2021 | Pacira Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,236.04 | General |
| 05/31/2021 | Pacira Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,581.34 | General |
| 05/03/2021 | Pacira Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $10,000.00 | General |
| 06/13/2019 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| 05/30/2019 | JAZZ PHARMACEUTICALS INC. | — | Consulting Fee | Cash or cash equivalent | $7,315.00 | General |
| 05/14/2019 | Halozyme Inc | — | Consulting Fee | Cash or cash equivalent | $1,195.46 | General |
| 12/12/2018 | Halozyme Inc | — | Consulting Fee | Cash or cash equivalent | $1,025.06 | General |
| 10/30/2018 | Halozyme Inc | — | Consulting Fee | Cash or cash equivalent | $3,075.19 | General |
| 10/08/2018 | Halozyme Inc | — | Consulting Fee | Cash or cash equivalent | $439.32 | General |
| 12/06/2017 | UCB SA | — | Travel and Lodging | In-kind items and services | $147.00 | General |
| 11/14/2017 | Novartis Pharma AG | ACZ885D (Biological) | Consulting Fee | Cash or cash equivalent | $55.13 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2017 | UCB SA | — | Consulting Fee | In-kind items and services | $18,750.00 | General |
| 11/11/2017 | UCB SA | — | Food and Beverage | In-kind items and services | $125.36 | General |
| 11/07/2017 | Novartis Pharma AG | ACZ885D (Biological) | Consulting Fee | Cash or cash equivalent | $750.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2017 | UCB SA | — | Consulting Fee | In-kind items and services | $4,630.62 | General |
| 10/11/2017 | UCB SA | — | Travel and Lodging | In-kind items and services | $177.00 | General |
| 10/11/2017 | UCB SA | — | Food and Beverage | In-kind items and services | $97.06 | General |
| 10/11/2017 | UCB SA | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 09/11/2017 | UCB SA | — | Travel and Lodging | In-kind items and services | $177.00 | General |
| 09/11/2017 | UCB SA | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 08/11/2017 | UCB SA | — | Travel and Lodging | In-kind items and services | $177.00 | General |
About Dr. Carl Peck, M.D
Dr. Carl Peck, M.D is a Clinical Pharmacology healthcare provider based in San Luis Obispo, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2009. The National Provider Identifier (NPI) number assigned to this provider is 1073755302.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carl Peck, M.D has received a total of $84,855 in payments from pharmaceutical and medical device companies, with $3,924 received in 2022. These payments were reported across 38 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($80,377).
Practice Information
- Specialty Clinical Pharmacology
- Location San Luis Obispo, CA
- Active Since 04/01/2009
- Last Updated 04/01/2009
- Taxonomy Code 208U00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1073755302
Products in Payments
- ACZ885D (Biological) $8,569
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.